JPMorgan Chase & Co. acquired a new position in shares of Varex Imaging (NASDAQ:VREX) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 76,769 shares of the company’s stock, valued at approximately $2,595,000. JPMorgan Chase & Co. owned about 0.20% of Varex Imaging at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in VREX. Hussman Strategic Advisors Inc. acquired a new stake in Varex Imaging during the second quarter worth about $147,000. Independent Order of Foresters acquired a new stake in shares of Varex Imaging during the second quarter valued at about $243,000. Seaward Management Limited Partnership acquired a new stake in shares of Varex Imaging during the second quarter valued at about $213,000. Schwab Charles Investment Management Inc. acquired a new stake in shares of Varex Imaging during the second quarter valued at about $5,349,000. Finally, Foundry Partners LLC acquired a new stake in shares of Varex Imaging during the second quarter valued at about $455,000. Hedge funds and other institutional investors own 91.72% of the company’s stock.
Shares of Varex Imaging (NASDAQ:VREX) opened at 33.02 on Friday. The firm’s 50 day moving average is $30.08 and its 200-day moving average is $32.62. The firm has a market capitalization of $1.24 billion and a PE ratio of 21.13. Varex Imaging has a 12 month low of $25.00 and a 12 month high of $36.58.
Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $0.44 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.51 by ($0.07). The firm had revenue of $170.00 million for the quarter, compared to analyst estimates of $179.05 million. The business’s revenue for the quarter was up 12.6% compared to the same quarter last year. On average, analysts expect that Varex Imaging will post $1.59 EPS for the current fiscal year.
A number of equities research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Varex Imaging from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 5th. J P Morgan Chase & Co cut shares of Varex Imaging from a “neutral” rating to an “underweight” rating and set a $33.00 price target for the company. in a research report on Wednesday, October 4th. Finally, Jefferies Group LLC assumed coverage on shares of Varex Imaging in a research report on Wednesday, August 9th. They set a “buy” rating and a $34.00 price target for the company.
Varex Imaging Company Profile
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.
Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX).
What are top analysts saying about Varex Imaging? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Varex Imaging and related companies.